Literature DB >> 19907099

GH-releasing peptide-2 does not stimulate arginine vasopressin secretion in healthy men.

Kyuzi Kamoi1, Shinichi Minagawa, Keita Kimura, Masahiro Ishizawa, Nobumasa Ohara, Yasuyuki Uemura, Junpei Tsuchiya.   

Abstract

Ghrelin has a stimulating effect on arginine vasopressin (AVP). However, it is not known whether GHRP-2, a synthetic ghrelin receptor agonist, also has a stimulating effect on AVP release in men. To determine whether the GHRP-2 test is useful for assessing AVP secretion, blood ACTH, GH, FSH, LH, PRL, TSH and AVP levels, as well as glucose, osmolality, sodium and hematocrit, were measured before and 15, 30, 45 and 60 min after an intravenous bolus of 100 microg GHRP-2 in 10 healthy men with and without fasting. Blood pressure was measured at 15-min intervals. AVP secretion was not stimulated by the GHRP-2 test with and without fasting. There were no significant differences in hematocrit, blood pressure and plasma osmolality before and after GFRP-2 injection, although significant (p<0.001) peak blood GH, and ACTH and PRL levels were observed 30 and 15 min after GHRP-2 injection with and without fasting, respectively, and the maximal peaks were significantly (p<0.05) higher with fasting than without fasting. These results suggest that AVP secretion is not stimulated by the GHRP-2 test both with and without fasting, though GH, ACTH and PRL levels were higher with than without fasting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19907099     DOI: 10.1507/endocrj.k09e-215

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  1 in total

1.  Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.

Authors:  Sawako Suzuki; Yutarou Ruike; Kazuki Ishiwata; Kumiko Naito; Katsushi Igarashi; Akiko Ishida; Masanori Fujimoto; Hisashi Koide; Kentaro Horiguchi; Ichiro Tatsuno; Koutaro Yokote
Journal:  J Endocr Soc       Date:  2022-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.